About
Activity
-
For a year and a half, I’ve helped schedule, organize, and host monthly calls for Accenture’s Strategy Life Sciences community of practice. On these…
For a year and a half, I’ve helped schedule, organize, and host monthly calls for Accenture’s Strategy Life Sciences community of practice. On these…
Liked by Ray Pressburger
-
At Accenture, we maintain that viability of the cell & gene therapy business model is at risk. We are hiding behind the hubris of science. The cost…
At Accenture, we maintain that viability of the cell & gene therapy business model is at risk. We are hiding behind the hubris of science. The cost…
Liked by Ray Pressburger
-
August is #NationalImmunizationAwarenessMonth, a time for those of us working in #vaccines and the broader public health community to redouble our…
August is #NationalImmunizationAwarenessMonth, a time for those of us working in #vaccines and the broader public health community to redouble our…
Liked by Ray Pressburger
Experience & Education
-
Accenture
View Ray’s full experience
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Publications
-
The Next Era of Commercialization in Life Sciences
Accenture
See publicationHow Life Sciences companies are reinventing for a more modern and sustainable approach
-
An Economic Path Forward: Thoughts on an Industry Inflection Point
Pharmaceutical Commerce
A perspective on the path forward for Life Sciences and Healthcare to adapt to the economic pressures we all face
Other authors -
-
The New Economics of Life Sciences
Accenture
How the economic landscape is shaping the approach to bringing new science to market
Other authors -
-
For Life Sciences, No Time to Waste: Monetizing Outcomes
See publicationNew technologies now allow life sciences companies to pursue “outcomes-based” commercial models that directly tie their reimbursements to the real-world outcomes their patients experience. Such arrangements are likely to revolutionize the industry. While companies focused on certain therapeutic areas will adapt first, all companies will eventually need to capitalize on digital investments to define, monitor and improve patient outcomes. Those that embrace the outcomes-based commercial…
New technologies now allow life sciences companies to pursue “outcomes-based” commercial models that directly tie their reimbursements to the real-world outcomes their patients experience. Such arrangements are likely to revolutionize the industry. While companies focused on certain therapeutic areas will adapt first, all companies will eventually need to capitalize on digital investments to define, monitor and improve patient outcomes. Those that embrace the outcomes-based commercial opportunity early will have the best chance of not only regaining control of key profitability levers, but also influencing the industry’s shift to a healthier financial model.
-
The Rebirth of the Pharmaceutical Sales Force
Accenture
More activity by Ray
-
I’m honored to have been interviewed by @Authority Magazine to discuss the transformative impact of #AI on #MedTech. A special thanks to @Cynthia…
I’m honored to have been interviewed by @Authority Magazine to discuss the transformative impact of #AI on #MedTech. A special thanks to @Cynthia…
Liked by Ray Pressburger
-
We are looking for an experienced strategy consulting professional to come join our team as we reinvent the commercial model and launch new and…
We are looking for an experienced strategy consulting professional to come join our team as we reinvent the commercial model and launch new and…
Shared by Ray Pressburger
-
We are looking for an exceptional leader with deep expertise in R&D who can help transform the industry together with our growing team
We are looking for an exceptional leader with deep expertise in R&D who can help transform the industry together with our growing team
Shared by Ray Pressburger
-
A few days ago, my son Nolan and I had the distinct pleasure and honor of visiting over 100 primary and middle school children in the village of…
A few days ago, my son Nolan and I had the distinct pleasure and honor of visiting over 100 primary and middle school children in the village of…
Liked by Ray Pressburger
-
As part of Pfizer’s #175daysofgood commemorating our 175th birthday, I had the privilege to volunteer today for an amazing organization…
As part of Pfizer’s #175daysofgood commemorating our 175th birthday, I had the privilege to volunteer today for an amazing organization…
Liked by Ray Pressburger
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More